BLBAUPOST GROUP LLC/MA
Institutional investor · Portfolio as of Q1 2020
Top Holdings33 positions
EBAY INC. | 32.1M | $964.5M | 14.2% | $28.26 | +0.17% | 6 qtrssince 2018-Q4 | Increased 90 |
LIBERTY GLOBAL PLC | 53.7M | $843.7M | 12.5% | — | — | 6 qtrssince 2018-Q4 | Increased 64 |
FOX CORP | 27.3M | $645.6M | 9.5% | $33.43 | -32.43% | 5 qtrssince 2019-Q1 | Unchanged 0 |
VIASAT INC COM | 13.7M | $493.3M | 7.3% | $58.03 | -33.64% | 6 qtrssince 2018-Q4 | Unchanged 0 |
Alphabet Inc. | 300,500 | $349.4M | 5.2% | $57.60 | 0.00% | 1 qtr | New 97 |
HP INC | 20M | $347.2M | 5.1% | $15.66 | -6.45% | 2 qtrssince 2019-Q4 | Increased 98 |
Meta Platforms Inc | 2M | $330.9M | 4.9% | $164.80 | 0.00% | 1 qtr | New 87 |
VIACOMCBS INC | 22.5M | $315.2M | 4.7% | — | — | 2 qtrssince 2019-Q4 | Increased 74 |
CHENIERE ENERGY INC | 8.1M | $272.2M | 4.0% | $56.31 | +393.99% | 6 qtrssince 2018-Q4 | Decreased 0 |
QORVO INC | 3.1M | $246.9M | 3.6% | $62.90 | +29.54% | 6 qtrssince 2018-Q4 | Increased 64 |
MCKESSON CORP | 1.7M | $225.8M | 3.3% | $112.57 | +18.11% | 6 qtrssince 2018-Q4 | Increased 60 |
THERAVANCE BIOPHARMA INC | 9.3M | $215.1M | 3.2% | $23.43 | -1.58% | 6 qtrssince 2018-Q4 | Unchanged 0 |
HD SUPPLY HLDGS INC | 6.2M | $176.8M | 2.6% | — | — | 1 qtr | New 80 |
Telesis Bio, Inc. | 17.5M | $171.1M | 2.5% | — | — | 6 qtrssince 2018-Q4 | Unchanged 0 |
AKEBIA THREAPEUTICS INC COM | 17.5M | $132.9M | 2.0% | $5.39 | +47.68% | 6 qtrssince 2018-Q4 | Decreased 0 |
FOX CORP | 5.7M | $130M | 1.9% | $32.49 | -32.38% | 5 qtrssince 2019-Q1 | Unchanged 0 |
LIBERTY GLOBAL PLC | 7.7M | $126.4M | 1.9% | — | — | 6 qtrssince 2018-Q4 | Unchanged 0 |
NEXSTAR MEDIA GROUP INC | 2.1M | $120.4M | 1.8% | $71.98 | -30.79% | 6 qtrssince 2018-Q4 | Increased 51 |
PG&E CORP | 9.7M | $87.2M | 1.3% | $21.40 | -55.33% | 6 qtrssince 2018-Q4 | Decreased 0 |
COLONY CAP INC NEW | 49.7M | $87M | 1.3% | — | — | 6 qtrssince 2018-Q4 | Unchanged 0 |
BAUPOST GROUP LLC/MA manages $6.8B across 33 positions as of Q1 2020. Top holdings: EBAY (14.2%), LBYKV (12.5%), FOXA (9.5%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 4.5/5.0.
Active quarter - 8 new positions, 6 exits, 8 increased. Top move: HPQ (INCREASED, conviction 98). Portfolio: $6.8B across 33 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR